iFANN
    Buscar en iFANN...
    Iniciar sesión
    Inicio
    Noticias
    Vídeos
    Fotos
    GIFs
    Explorar
    Encuestas
    Premios
    iFAMOUS
    Wiki
    Anime
    Salas
    Notificaciones
    Mensajes
    Guardados
    Perfil
    WikiPremiosiFAMOUSClasificacionesSectoresRecompensas para creadoresRecompensas para usuariosTérminosPrivacidadNormas de la comunidadRetirada / DMCAAyudaDesarrolladores

    © 2026 iFANN

    Inicio
    Buscar
    Mensajes
    Alertas
    Perfil

    Publicación

    Brokenboba
    Brokenboba@brokenboba
    🏛️Harvard University💭Viral Content💭Health

    Lito Souza Creutzfeldt-Jakob appeal

    Health Minister Alexandre Padilha says the Ministry is in contact with institutions researching prion diseases, including Creutzfeldt-Jakob disease. Lito Sousa has this condition and is making an urgent appeal to Ionis Pharmaceuticals, the Broad Institute, Harvard, and Mayo Clinic. Creutzfeldt-Jakob is a rapidly advancing and mostly fatal disease with no standard treatment protocol. As a Brazilian influencer with millions of followers, Lito Souza's family is seeking to get him into an experimental trial involving two potential studies.

    3w

    27 Me gusta1 No me gusta2 Reposteos1 Comentarios
    ?

    Comentarios

    Aún no hay comentarios. ¡Sé el primero!

    Publicación

    Brokenboba
    Brokenboba@brokenboba
    🏛️Harvard University💭Viral Content💭Health

    Lito Souza Creutzfeldt-Jakob appeal

    Health Minister Alexandre Padilha says the Ministry is in contact with institutions researching prion diseases, including Creutzfeldt-Jakob disease. Lito Sousa has this condition and is making an urgent appeal to Ionis Pharmaceuticals, the Broad Institute, Harvard, and Mayo Clinic. Creutzfeldt-Jakob is a rapidly advancing and mostly fatal disease with no standard treatment protocol. As a Brazilian influencer with millions of followers, Lito Souza's family is seeking to get him into an experimental trial involving two potential studies.

    3w

    27 Me gusta1 No me gusta2 Reposteos1 Comentarios
    ?

    Comentarios

    Aún no hay comentarios. ¡Sé el primero!